$2.07
-0.15-6.76%
Last update: 1:57 PM
15 minutes delayed
Comments
Loading...
Tempest Therapeutics
TPSTNASDAQ
want to know what
the Bulls & Bears Say?
Tempest Therapeutics (NASDAQ:TPST) Stock, Analyst Ratings, Price Targets, Forecasts
Tempest Therapeutics Inc has a consensus price target of $19.4 based on the ratings of 6 analysts. The high is $47 issued by HC Wainwright & Co. on June 20, 2024. The low is $8 issued by Piper Sandler on June 21, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co. on June 21, 2024, June 20, 2024, and May 13, 2024, respectively. With an average price target of $34 between Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1542.51% upside for Tempest Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
HC Wainwright & Co.
Scotiabank
Jefferies
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Tempest Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | Buy Now | 286.47% | Piper Sandler | Edward Tenthoff | $8 → $8 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | $47 → $47 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | → $47 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | → $47 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | $47 → $47 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | 528.02% | Scotiabank | George Farmer | → $13 | Initiates | → Sector Outperform | Get Alert |
| 03/13/2024 | Buy Now | 528.02% | Scotiabank | George Farmer | → $13 | Initiates | → Sector Outperform | Get Alert |
| 03/12/2024 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | $47 → $47 | Maintains | Buy | Get Alert |
| 02/08/2024 | Buy Now | 624.64% | Jefferies | Maury Raycroft | → $15 | Initiates | → Buy | Get Alert |
| 10/11/2023 | Buy Now | 2170.53% | HC Wainwright & Co. | Joseph Pantginis | $35 → $47 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Reiterates | Buy → Buy | Get Alert |
| 04/28/2023 | Buy Now | 576.33% | Ladenburg Thalmann | Aydin Huseynov | $8 → $14 | Maintains | Buy | Get Alert |
| 03/23/2023 | Buy Now | 189.86% | Piper Sandler | Edward Tenthoff | $10 → $6 | Maintains | Overweight | Get Alert |
| 03/23/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | → $35 | Maintains | Buy | Get Alert |
| 09/15/2022 | Buy Now | 286.47% | Ladenburg Thalmann | Aydin Huseynov | → $8 | Initiates | → Buy | Get Alert |
| 05/16/2022 | Buy Now | 1590.82% | HC Wainwright & Co. | Joseph Pantginis | $51 → $35 | Maintains | Buy | Get Alert |
| 10/21/2021 | Buy Now | — | William Blair | Matt Phipps | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Tempest Therapeutics (TPST) stock?
The latest price target for Tempest Therapeutics (NASDAQ:TPST) was reported by Piper Sandler on June 21, 2024. The analyst firm set a price target for $8.00 expecting TPST to rise to within 12 months (a possible 286.47% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tempest Therapeutics (TPST)?
The latest analyst rating for Tempest Therapeutics (NASDAQ:TPST) was provided by Piper Sandler, and Tempest Therapeutics reiterated their overweight rating.
When was the last upgrade for Tempest Therapeutics (TPST)?
There is no last upgrade for Tempest Therapeutics
When was the last downgrade for Tempest Therapeutics (TPST)?
There is no last downgrade for Tempest Therapeutics.
When is the next analyst rating going to be posted or updated for Tempest Therapeutics (TPST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tempest Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tempest Therapeutics was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
Is the Analyst Rating Tempest Therapeutics (TPST) correct?
While ratings are subjective and will change, the latest Tempest Therapeutics (TPST) rating was a reiterated with a price target of $8.00 to $8.00. The current price Tempest Therapeutics (TPST) is trading at is $2.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.